Clinical trial

A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens

NCT04238962

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-02-03

PhasePHASE1

Study timeline

Study start (actual)2020-02-03Date precision: day

Registry last updated2020-11-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Overweightunresolved

Obesityunresolved

Interventions

Semaglutide (administered by DV3396 pen-injector)DRUG

Semaglutide (administered by PDS290 pen-injector)DRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04238962 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.